Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice

Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice

Obesity and its associated metabolic dysfunction and cardiovascular disease risk represent a leading cause of adult morbidity worldwide. Currently available pharmacological therapies for obesity have had limited success in reversing existing obesity and metabolic dysregulation. Previous prevention s...

Full description

Bibliographic Details
Main Authors:	Amy C. Burke, Brian G. Sutherland, Dawn E. Telford, Marisa R. Morrow, Cynthia G. Sawyez, Jane Y. Edwards, Maria Drangova, Murray W. Huff
Format:	Article
Language:	English
Published:	Elsevier 2018-09-01
Series:	Journal of Lipid Research
Subjects:	steatohepatitis beta oxidation insulin resistance hypolipidemic drugs low density lipoprotein receptor-deficient mice
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520335409

Similar Items

The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S]
by: Nadya M. Morrow, et al.
Published: (2020-03-01)

Anti-Obesity Effect of Artemisia capillaris Extracts in High-Fat Diet-Induced Obese Rats
by: Yu-Jung Jang, et al.
Published: (2013-08-01)

Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4α
by: Vered Sheena, et al.
Published: (2005-02-01)

Current therapies for lowering lipoprotein (a)
by: Julian C. van Capelleveen, et al.
Published: (2016-09-01)

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice[S]
by: Julia M. Assini, et al.
Published: (2013-03-01)

The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab[S]
by: Byambaa Enkhmaa, et al.
Published: (2017-10-01)

Hypolipidemic effect of Silymarin in Dyslipidaemia of Different Etiologies
by: Bahir Abdul Razzaq Mesheimish, et al.
Published: (2008-01-01)

Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation
by: Erin E. Mulvihill, et al.
Published: (2012-01-01)

Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis
by: George Thanassoulis
Published: (2016-06-01)

Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr−/− mice[S]
by: Jinghua Bie, et al.
Published: (2014-04-01)

Effect of Morinda citrifolia (Noni) Fruit Juice on High Fat Diet Induced Dyslipidemia in Rats
by: Ahsan Shoeb, et al.
Published: (2016-04-01)

Study the Effect of S-Methyl L-Cysteine on Lipid Metabolism in an Experimental Model of Diet Induced Obesity
by: Senthilkumar G.P., et al.
Published: (2013-11-01)

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9[S]
by: Sam J.L. van der Tuin, et al.
Published: (2015-11-01)

Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats
by: Santiagu Stephen Irudayaraj, et al.
Published: (2017-01-01)

Hypolipidemic effects of fenugreek seed powder
by: Abu Saleh M. Moosa, et al.
Published: (2006-12-01)

Antihyperglycemic and antihyperlipidemic effects of low-molecular-weight carrageenan in rats
by: Qiu Xia, et al.
Published: (2018-10-01)

Hypolipidemic effects of fenugreek seed powder
by: Abu Saleh M. Moosa, Mamun Ur Rashid, A.Z.S. Asadi, Nazma Ara, M. Mojib Uddin and A. Ferdaus
Published: (2006-12-01)

Lime (<i>Citrus aurantifolia</i> (Christm.) Swingle) Essential Oils: Volatile Compounds, Antioxidant Capacity, and Hypolipidemic Effect
by: Li-Yun Lin, et al.
Published: (2019-09-01)

A SINGLE MECHANISM OF ACTION OF HYPOLIPIDEMIC DRUGS. BASIC PRINCIPLES OF PRIMARY PREVENTION OF ATHEROSCLEROSIS, ATHEROMATOSIS AND CORONARY SYNDROME
by: V. N. Titov, et al.
Published: (2014-12-01)

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013-08-01)

Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01)

Light Chain Myeloma induced Severe Hypertriglyceridemia
by: Shafeeque Rahman, et al.
Published: (2017-03-01)

Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity
by: Cacilda Pedrosa de Oliveira, et al.
Published: (2007-10-01)

Potential role of a nutraceutical spice (Allium hirtifolium) in reduction of atherosclerotic plaques
by: Rafieian-kopaei Mahmoud, et al.
Published: (2013-04-01)

RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
by: Advisory Board
Published: (2017-06-01)

Antihyperlipidemic effect of diosmin: A citrus flavonoid on lipid metabolism in experimental diabetic rats
by: Subramani Srinivasan, et al.
Published: (2013-01-01)

Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021-05-01)

Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia[S]
by: Elizabeth A. O'Hare, et al.
Published: (2014-11-01)

Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease
by: Cheng-Maw Ho, et al.
Published: (2019-04-01)

Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]
by: Tobias Kroon, et al.
Published: (2017-01-01)

Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-γ
by: Stewart C. Whitman, et al.
Published: (1999-06-01)

The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatins⃞
by: Dawn E. Telford, et al.
Published: (2007-03-01)

Comparative pharmacoepidemiological assessment of antianginal, antiplatelet and lipid-lowering drugs in patients with stable angina in outpatient practice in Kursk and Chisinau
by: Sergey V. Povetkin, et al.
Published: (2019-09-01)

In silico Studies Combining QSAR Models, DFT-based Reactivity Descriptors and Docking Simulations of Phthalimide Congeners with Hypolipidemic Activity
by: Maria Angélica Oliveira, et al.
Published: (2021-07-01)

Investigations on the anti-diabetic potential of novel marine seaweed Sargassum longiotom against alloxan-induced diabetes mellitus: A pilot study
by: Stalin Selvaraj, et al.
Published: (2014-06-01)

Evidence-based grounds of the efficacy of simvastatin (zocor): 15 years later
by: Andrey Vladimirovich Susekov, et al.
Published: (2010-12-01)

Investigations on the anti-diabetic potential of novel marine seaweed Sargassum longiotom against alloxan-induced diabetes mellitus: A pilot study
by: Stalin Selvaraj, et al.
Published: (2014-04-01)

Potential anti-diabetic activity of Bombax ceiba
by: Chetan Bhavsar, et al.
Published: (2013-02-01)

Hypolipidemic effect of aqueous extract from the leaves of Artocarpus altilis "breadfruit" in Rattus norvegicus induced hyperlipidemia
by: Julio Campos Florián
Published: (2013-12-01)

TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
by: V. A. Korneva, et al.
Published: (2015-09-01)